U.S. Energy Services Stock News

Tapestry (TPR) recently raised its fiscal 2026 outlook, guiding to revenues above US$7.75b and EPS growth of 25%. This shift has sharpened investor focus on what is driving the stock. See our latest analysis for Tapestry. Tapestry's recent outlook upgrade sits alongside a strong share price run, with a 30 day share price return of 18.82% and a 1 year total shareholder return of 86.84% suggesting momentum has been building rather than fading. If this kind of momentum has you thinking about...

Why IDEX (IEX) is on investors’ radar today IDEX (IEX) is drawing attention after a period of steady share price movement, with recent returns and current valuation metrics prompting investors to reassess how the company’s fundamentals line up with its current price. See our latest analysis for IDEX. At a share price of $208.45, IDEX has seen steady momentum recently, with a 30-day share price return of 6.75% and a 90-day share price return of 19.96%. The 1-year total shareholder return of...

If you are wondering whether Bruker is priced attractively right now, you are not alone, especially with sentiment around the stock shifting recently. The share price closed at US$39.77, with a 4.3% gain over the last 7 days, set against returns of a 21.0% decline over 30 days, a 17.3% decline year to date, and a 21.6% decline over 1 year, as well as 41.7% and 35.1% declines over 3 and 5 years respectively. These mixed shorter term and longer term returns have put more attention on what...

Why Realty Income is on investors’ radar today Realty Income (O) is drawing fresh interest after recent share price moves, with the stock last closing at $66.52. For income focused investors, that prompts a closer look at its current profile. See our latest analysis for Realty Income. Recent moves fit into a stronger run, with a 30-day share price return of 9.52% and a 90-day share price return of 16.42%, while the 1-year total shareholder return of 25.07% points to building momentum around...

In recent days, Jefferies downgraded monday.com from Buy to Hold, and several other analysts also reassessed their views on the company, signaling increased caution about its near-term prospects. This shift in analyst sentiment highlights growing scrutiny of monday.com's execution risks, competitive positioning, and the sustainability of its growth-focused business model. We’ll now examine how this broad reset in analyst sentiment could reshape monday.com’s investment narrative and its...

Earlier this week, Tenable Holdings, a cybersecurity and vulnerability management provider, came under pressure after the White House announced plans to lift global tariffs to 15%, sparking renewed concern about trade policy and its knock-on effects for technology and software firms. At the same time, investors are weighing Tenable’s ongoing profitability and liquidity challenges against sector worries that rapid advances in artificial intelligence could reshape demand for traditional...

If you are wondering whether TG Therapeutics at around US$30.51 is priced attractively or already baking in a lot of optimism, you are in the right place. The stock has returned 5.0% over the last 7 days, is down 2.2% over 30 days, and shows mixed longer term results with a 4.2% return year to date, 4.5% over 1 year, 90.4% over 3 years, and a 32.0% decline over 5 years. These moves sit against a backdrop of ongoing interest in TG Therapeutics as a biotechnology name, with investors watching...

TKO Group Holdings (NYSE:TKO) is preparing to stage the WWE Chamber event, a major wrestling showcase on its global calendar. The company is also organizing UFC Mexico, bringing a flagship mixed martial arts card to a key international market. These events are expected to attract substantial international audiences and media attention across multiple platforms. For you as an investor, these upcoming cards highlight what TKO Group Holdings really is: a live sports entertainment operator...

Entergy (ETR) is back in focus after the utility asked for proposals for up to 1 GW of new gas fired generation in Southeast Texas, tying directly into its long term Southeast Texas Energy Plan. See our latest analysis for Entergy. That request for up to 1 GW of new gas fired capacity comes after a period where Entergy’s share price return has been firming, with a 12.9% 30 day move and a 26.5% one year total shareholder return, suggesting investors are weighing both growth plans and recent...

Exxon Mobil (XOM) is back in focus after reporting strong production growth, rolling out new projects, and reiterating long term earnings goals, while simultaneously contesting high profile legal and arbitration cases. See our latest analysis for Exxon Mobil. The latest share price of US$149.26 sits on the back of strong recent momentum, with a 30 day share price return of 10.59% and a 30.05% 90 day move. The 1 year total shareholder return of 40.70% and 5 year total shareholder return above...

In recent weeks, Flutter Entertainment responded to sector pressure after rival DraftKings issued cautious 2026 revenue guidance, prompting investors to reassess U.S. online betting prospects and competitive positioning. Flutter’s leadership emphasized FanDuel’s 47% U.S. market share and the breadth of its international portfolio, underlining how product innovation such as FanDuel Predict and geographic diversification underpin its business case. We’ll now explore how Flutter’s reaffirmed...

Ivanhoe Electric (IE) has come back into focus after reporting full year 2025 results, with sales of US$3.24 million and a net loss of US$105.87 million, alongside a narrower basic loss per share. See our latest analysis for Ivanhoe Electric. The latest earnings report appears to be one of the key reference points for investors. The 1 day share price return of 5.07% and 7 day share price return of 5.96% followed a 30 day share price return decline of 17.62%. The 1 year total shareholder...

Stock performance check in on Federal Agricultural Mortgage Federal Agricultural Mortgage (AGM) has drawn attention after a mixed run in its share price, with a 1 day gain of 1.7% but declines over the past week, month, and past 3 months. For investors tracking longer horizons, the stock shows a year to date total return of about a 10.3% decline and a 1 year total return of roughly a 19.9% decline, alongside reported annual revenue growth of 15.4% and net income growth of 8.7%. See our latest...

If you are wondering whether Lam Research is still fairly priced after its strong run, you are not alone. This article will focus squarely on what you might be paying for today. The stock last closed at US$244.25, with returns of 3.7% over 7 days, 12.1% over 30 days, 32.0% year to date, 207.0% over 1 year and 418.6% over 3 years. This naturally raises questions about how much of the story is already in the price. Recent coverage around Lam Research has focused on its role as a key supplier...

Moody's (NYSE:MCO) has set up a new regional headquarters in Riyadh, Saudi Arabia. The move is part of the company’s plan to support the Kingdom’s capital markets and its broader Middle East presence. The Riyadh hub aligns with Saudi Arabia’s Vision 2030 initiative and reflects Moody's focus on geographical expansion. Moody's is known for its credit ratings, research, and risk analysis, which are widely used by investors and issuers to assess creditworthiness and market conditions. By...

Allegion (ALLE) is back in focus after its fourth quarter 2025 results and fresh 2026 guidance, which paired solid margin performance with softer residential trends and a more cautious tone from analysts. See our latest analysis for Allegion. Allegion’s recent earnings, 2026 guidance and new Schlage product launches have come against a softer patch for the shares, with a 30 day share price return of 4.76% and a 90 day share price return of 4.11%, while the 1 year total shareholder return of...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

How D.R. Horton Stock Has Been Performing D.R. Horton (DHI) has seen mixed recent returns, with a small 0.2% decline over the past day and a 1.4% pullback over the past week, alongside a gain over the past month. Over longer periods, the stock shows a 4.6% return over the past 3 months, 12.5% year to date, and 25.6% over the past year, with multi year total returns that are also positive. See our latest analysis for D.R. Horton. At a share price of $163.95, D.R. Horton’s 8.9% 1 month share...

Why Silicon Motion Technology (SIMO) Is Getting Fresh Attention Silicon Motion Technology (SIMO) is back on many watchlists after a period of strong quarterly earnings and revenue growth, combined with technical signals that point to firm price momentum. In addition, analysts have recently lifted their earnings estimates, which many investors read as confirmation that the business performance trends seen in the latest quarter may have some continuity in the near term. See our latest analysis...

What Teradata’s recent returns signal for investors Teradata (TDC) has delivered mixed share price moves, with a roughly 6.8% gain over the past day, a 7.9% decline over the past week, and positive returns over the past month and past 3 months. At a last close of $30.03, the company has a 1 year total return of about 23.6%. Its 3 year and 5 year total returns are both negative, which may catch the eye of investors comparing shorter and longer time frames. See our latest analysis for...

In February 2026, Safehold Inc. reported fourth-quarter and full-year 2025 results showing modest increases in sales, revenue, net income, and earnings per share, and confirmed that no shares were repurchased under the buyback program announced in February 2025. Alongside this, Safehold expanded its ground lease portfolio to 143 assets worth about US$6.50 billion and secured a new US$2.00 billion unsecured revolving credit facility, meaningfully increasing its financial flexibility to...

If you are trying to work out whether Caris Life Sciences at around US$18.20 is a bargain or a value trap, you are in the right place. The stock has been under pressure recently, with a 12.5% decline over the last 7 days, a 27.2% decline over the last 30 days, and a 32.5% decline year to date. Recent attention around Caris Life Sciences has focused on its position in the pharmaceuticals and biotech space and how investors are reassessing risk in the sector. This backdrop helps explain why...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

If you are wondering whether Inspire Medical Systems' share price now reflects good value or lingering risk, you are not alone. The stock last closed at US$57.72, with returns of 4.4% decline over 7 days, 27.3% decline over 30 days, 37.4% decline year to date, 68.8% decline over 1 year, 77.8% decline over 3 years and 76.1% decline over 5 years. Recent coverage has focused on how the share price pullback has reshaped expectations around the company and the sleep apnea treatment market it...